Daniel Weinbach, president and CEO of nationally-recognized healthcare marketing firm The Weinbach Group, was recently quoted in an article in Barron’s discussing proposed reforms by the U.S. Department of Health and Human Services and the Food and Drug Administration that target direct-to-consumer prescription drug advertising.

The Weinbach Group announced today that it is among a select group of companies that will participate in the U.S. Department of Veterans Affairs (VA) Integrated Healthcare Transformation (IHT) 2.0 contract. The 10-year, $14 billion initiative is designed to improve healthcare delivery for veterans across the nation.

The Weinbach Group Takes Home Multiple Honors At The 42nd Annual Healthcare Advertising Awards The Weinbach Group won several gold awards...

In this exclusive interview, Weinbach shares the key strategies that have positioned his firm as a national leader, from navigating...

This article was originally published on HealthcareMarketingAgency.com . Republished with permission. Healthcare marketing plays a...

This article was originally published on HealthcareMarketingAgency.com . Republished with permission. In the ever-evolving landscape of...